/
•
•
Context is everything.
Detailed stories on technology startups, business and economic current affairs.
Detailed stories on technology startups, business and economic current affairs.
The investment giant is rumoured to be eyeing an exit with a 5x return, having taken the drugmaker from obscurity to a billion-dollar bidding war.
The investment giant is rumoured to be eyeing an exit with a 5x return, having taken the drugmaker from obscurity to a billion-dollar bidding war.
The drugmaker’s reluctance to part with cash may have given it one of the strongest balance sheets in Indian pharma, but investors are increasingly rewarding risk takers.
Highlights from Saudi Arabia’s flagship FII conference, Tabby’s new valuation and UAE government bonds, among other updates.
Global investors are betting on Kerala’s healthcare boom. But it remains to be seen whether private capital can coexist with the state’s public ethos.
The drugmaker’s reluctance to part with cash may have given it one of the strongest balance sheets in Indian pharma, but investors are increasingly rewarding risk takers.
Highlights from Saudi Arabia’s flagship FII conference, Tabby’s new valuation and UAE government bonds, among other updates.
Global investors are betting on Kerala’s healthcare boom. But it remains to be seen whether private capital can coexist with the state’s public ethos.
